ArticleQuantitative imaging in medicine and surgery2025
Efficacy and safety of ultrasound-guided percutaneous aspiration-sclerotherapy with anhydrous ethanol for adult simple renal cyst: a multicenter, prospective, randomized controlled trial.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A z-score-based reference system for renal volume using three-dimensional ultrasound: from model to clinical tool.Quantitative imaging in medicine and surgery · 2026Article
- Divergent outcomes of delayed ureteropelvic junction stenosis after renal cyst sclerotherapy: two case reports.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Percutaneous aspiration-sclerotherapy (PAS) is one of the most common treatments for renal cysts. In this study, we conducted an unequal-group, superior, randomized controlled trial to evaluate the safety and efficacy of ultrasound-guided PAS with anhydrous ethanol involving single-session multiple injections for simple renal cysts (SRCs) in adults by comparing percutaneous aspiration therapy with or without sclerosis agents. Methods: We prospectively collected data from multiple healthcare organizations in China on 149 patients with SRCs from August 2017 to October 2018. The patients enrolled in the study underwent percutaneous aspiration therapy with (treatment group, n=120) or without (control group, n=29) anhydrous ethanol. Treatment success was defined as a reduction in renal cyst volume of 87.5% or more from pre-treatment volume after 24 weeks of treatment. All patients were followed up at weeks 12 and 24. The patient profiles, reduced volume of cysts, treatment success rates, recurrence rates, and complication rates of two groups were compared. Results: In this trial, the analysis of Full Analysis Set (FAS) revealed an average volume reduction of 93.4 mL in the treatment group (PAS with anhydrous ethanol) and 69.8 mL in the control group (percutaneous aspiration treatment) (P<0.01). At the 24-week follow-up, the treatment success rate of the treatment group was significantly higher than that of the control group (90.43% Conclusions: PAS with anhydrous ethanol combined with single-session multiple injections is a safe and effective treatment for SRCs. Trial Registration: Chinese Clinical Trial Registry identifier: ChiCTR-TRC-10001114.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.